Lets Talk Clots is made and published by vFairs. AppBrain is an independent app data site and isn't affiliated with vFairs. The app name, icon, screenshots and description belong to vFairs and are shown as published on Google Play.
AppBrain's verdict
Niche- Total installs
- 5 thousand
- Last updated
- October 20, 2026
Lets Talk Clots is a niche app, with 5 thousand installs. It doesn't have enough ratings yet to judge what users think.
Installs
Tracked by AppBrain- Last 30 days
- 140
- Play install range
- 1+ thousand
- Launched
- August 2023
Installs over time
Lets Talk Clots has been installed 5 thousand times. Over the past 30 days, it has been installed 140 times.
Rankings
Google Play top chartsGoogle Play Rankings for Lets Talk Clots
Competitors
Similar apps and more from vFairs
Releases
Updates seen on Google Play- Version
- 2.0.4
- Launched
- August 2023
User feedback
Ratings and reviews on Google PlayComments on Lets Talk Clots for Android
Technology
Found in the app by AppBrain- Ads
- No ads
- Price
- Free
- Libraries
- ?
- App size
- 108.4 MB
- Content rating
- Everyone
Technologies used by Lets Talk Clots
About the app and developer
About Lets Talk Clots
Lets Talk Clots is an education app developed by vFairs.
How many times has Lets Talk Clots been installed?
Lets Talk Clots has been installed 5 thousand times. In the last 30 days, the app was installed 140 times.
What is the rating of Lets Talk Clots?
Lets Talk Clots has no ratings yet.
Is Lets Talk Clots free?
Lets Talk Clots is free. The app size is 108.43 MB. The latest version available is 2.0.4. The last update was on October 20, 2026.
What are the requirements for Lets Talk Clots?
The app has a content rating of Everyone. The app has been available on Google Play since August 2023.
App Performance Report
Get a detailed PDF report for Lets Talk Clots with download trends, rating history, and key performance statistics — useful for competitive research or tracking your own app. Learn more
Get PDF Report — $29Developer information for vFairs
Frequently asked questions about Lets Talk Clots
Is Lets Talk Clots free?
Yes. Lets Talk Clots is free on Google Play.
Is Lets Talk Clots still available?
Yes. Lets Talk Clots is on Google Play, and the last update we saw was on October 20, 2026.
Does Lets Talk Clots contain ads?
No. Google Play does not list Lets Talk Clots as containing ads.
How large is Lets Talk Clots?
Lets Talk Clots is 108.43 MB.
Is Lets Talk Clots suitable for children?
Google Play rates the content of Lets Talk Clots as suitable for everyone.
How many times has Lets Talk Clots been installed?
Google Play lists 1,000+ installs for Lets Talk Clots.
Who made Lets Talk Clots?
Lets Talk Clots was developed by vFairs. It is listed in the education category on Google Play.
What are the best alternatives to Lets Talk Clots?
People looking at Lets Talk Clots also look at these education apps: All Blood Disease & Treatment, Doctor Diagnose Symptoms Check, Symptom to Diagnosis EB Guide, Nurse's Pocket Guide Diagnosis, Outcomes4Me Cancer Care.
Store listing
By vFairs, from Google Play“Information on blood clots – from risk, signs & symptoms to diagnosis & beyond”
Description by vFairs Written by the developer, not by AppBrain. Click to read.
The app shares key information about clots, reducing risk, signs, symptoms and diagnosis as well as recovery following a VTE diagnosis. The app includes sections on approved treatments and therapies, pain and ongoing symptom management.
Have been diagnosed? Information is also available about recovery, including managing anxiety and worry, regaining wellbeing, fitness and returning to everyday activities.
Life after a blood clot diagnosis, includes considerations around life events, including pregnancy, family planning, travel, work and managing other conditions alongside risk factors or a personal medical history of thrombosis.
Recent changes:
We're always working hard to optimize our app with the latest technologies and best new features. This version includes several UI/UX improvements as well as stability enhancements.
Enjoy!